This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsung, K.
Right arrow Articles by Norton, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsung, K.
Right arrow Articles by Norton, J. A.

 Previous Article  |  Next Article 

J. Virol., Jan 1996, 165-171, Vol 70, No. 1
Copyright © 1996, American Society for Microbiology

Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light

K Tsung, JH Yim, W Marti, RM Buller and JA Norton
Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

Induction of the cytopathic effect (CPE) in cells infected with poxvirus seems ubiquitous in that it has been associated with all different strains and preparations of poxviruses, regardless of the replicating status of these viruses. The study of the mechanisms by which CPE is induced by nonreplicating poxviruses is hampered by the lack of any noncytopathic mutant strains and preparations. In this paper, we report on the patterns of gene expression and induction of CPE by vaccinia viruses treated by limited cross-linking with psoralen and long-wave UV light (PLWUV). We show that treatment of cell-free virus with PLWUV could inactivate viral replication without abolishing the ability of the virus to infect cells. Viral transcription as indicated by reporter genes was generally enhanced and prolonged under early viral promoters and abolished under late promoters. Furthermore, increasing the levels of cross-linking with PLWUV resulted in a decrease and abolishment of viral expression of a large reporter gene and a concomitant loss of the induction of CPE. Cells infected with such a virus were able to express the reporter genes and proliferate. The generation of nonreplicating and noncytopathic recombinant vaccinia viruses may help in studies of the mechanisms of CPE induction by poxvirus and may facilitate the use of poxviral vectors in broader areas of research and clinical applications.


This article has been cited by other articles:

  • Benhnia, M. R.-E.-I., McCausland, M. M., Moyron, J., Laudenslager, J., Granger, S., Rickert, S., Koriazova, L., Kubo, R., Kato, S., Crotty, S. (2009). Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on Complement. J. Virol. 83: 1201-1215 [Abstract] [Full Text]  
  • Benhnia, M. R.-E.-I., McCausland, M. M., Su, H.-P., Singh, K., Hoffmann, J., Davies, D. H., Felgner, P. L., Head, S., Sette, A., Garboczi, D. N., Crotty, S. (2008). Redundancy and Plasticity of Neutralizing Antibody Responses Are Cornerstone Attributes of the Human Immune Response to the Smallpox Vaccine. J. Virol. 82: 3751-3768 [Abstract] [Full Text]  
  • Litzinger, M. T., Fernando, R., Curiel, T. J., Grosenbach, D. W., Schlom, J., Palena, C. (2007). IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity. Blood 110: 3192-3201 [Abstract] [Full Text]  
  • Fischer, M. A., Tscharke, D. C., Donohue, K. B., Truckenmiller, M. E., Norbury, C. C. (2007). Reduction of vector gene expression increases foreign antigen-specific CD8+ T-cell priming. J. Gen. Virol. 88: 2378-2386 [Abstract] [Full Text]  
  • Zhu, J., Martinez, J., Huang, X., Yang, Y. (2007). Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-{beta}. Blood 109: 619-625 [Abstract] [Full Text]  
  • Tang, J., Murtadha, M., Schnell, M., Eisenlohr, L. C., Hooper, J., Flomenberg, P. (2006). Human T-cell responses to vaccinia virus envelope proteins.. J. Virol. 80: 10010-10020 [Abstract] [Full Text]  
  • Najera, J. L., Gomez, C. E., Domingo-Gil, E., Gherardi, M. M., Esteban, M. (2006). Cellular and Biochemical Differences between Two Attenuated Poxvirus Vaccine Candidates (MVA and NYVAC) and Role of the C7L Gene.. J. Virol. 80: 6033-6047 [Abstract] [Full Text]  
  • Chisholm, S. E., Reyburn, H. T. (2006). Recognition of Vaccinia Virus-Infected Cells by Human Natural Killer Cells Depends on Natural Cytotoxicity Receptors. J. Virol. 80: 2225-2233 [Abstract] [Full Text]  
  • Palena, C., Foon, K. A., Panicali, D., Yafal, A. G., Chinsangaram, J., Hodge, J. W., Schlom, J., Tsang, K. Y. (2005). Potential approach to immunotherapy of chronic lymphocytic leukemia (CLL): enhanced immunogenicity of CLL cells via infection with vectors encoding for multiple costimulatory molecules. Blood 106: 3515-3523 [Abstract] [Full Text]  
  • Khan, I. H., Kendall, L. V., Ziman, M., Wong, S., Mendoza, S., Fahey, J., Griffey, S. M., Barthold, S. W., Luciw, P. A. (2005). Simultaneous Serodetection of 10 Highly Prevalent Mouse Infectious Pathogens in a Single Reaction by Multiplex Analysis. CVI 12: 513-519 [Abstract] [Full Text]  
  • Drillien, R., Spehner, D., Hanau, D. (2004). Modified vaccinia virus Ankara induces moderate activation of human dendritic cells. J. Gen. Virol. 85: 2167-2175 [Abstract] [Full Text]  
  • Crotty, S., Felgner, P., Davies, H., Glidewell, J., Villarreal, L., Ahmed, R. (2003). Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination. J. Immunol. 171: 4969-4973 [Abstract] [Full Text]  
  • Inoue, M., Tokusumi, Y., Ban, H., Kanaya, T., Shirakura, M., Tokusumi, T., Hirata, T., Nagai, Y., Iida, A., Hasegawa, M. (2003). A New Sendai Virus Vector Deficient in the Matrix Gene Does Not Form Virus Particles and Shows Extensive Cell-to-Cell Spreading. J. Virol. 77: 6419-6429 [Abstract] [Full Text]  
  • Inoue, M., Tokusumi, Y., Ban, H., Kanaya, T., Tokusumi, T., Nagai, Y., Iida, A., Hasegawa, M. (2003). Nontransmissible Virus-Like Particle Formation by F-Deficient Sendai Virus Is Temperature Sensitive and Reduced by Mutations in M and HN Proteins. J. Virol. 77: 3238-3246 [Abstract] [Full Text]  
  • Palmowski, M. J., Choi, E. M.-L., Hermans, I. F., Gilbert, S. C., Chen, J.-L., Gileadi, U., Salio, M., Van Pel, A., Man, S., Bonin, E., Liljestrom, P., Dunbar, P. R., Cerundolo, V. (2002). Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols. J. Immunol. 168: 4391-4398 [Abstract] [Full Text]  
  • Smith, V. P., Alcami, A. (2002). Inhibition of Interferons by Ectromelia Virus. J. Virol. 76: 1124-1134 [Abstract] [Full Text]  
  • Norbury, C. C., Princiotta, M. F., Bacik, I., Brutkiewicz, R. R., Wood, P., Elliott, T., Bennink, J. R., Yewdell, J. W. (2001). Multiple Antigen-Specific Processing Pathways for Activating Naive CD8+ T Cells In Vivo. J. Immunol. 166: 4355-4362 [Abstract] [Full Text]  
  • Wu, B., Wu, J.-M., Miagkov, A., Adams, R. N., Levitsky, H. I., Drachman, D. B. (2001). Specific Immunotherapy by Genetically Engineered APCs: The ""Guided Missile"" Strategy. J. Immunol. 166: 4773-4779 [Abstract] [Full Text]  
  • Smith, V. P., Alcami, A. (2000). Expression of Secreted Cytokine and Chemokine Inhibitors by Ectromelia Virus. J. Virol. 74: 8460-8471 [Abstract] [Full Text]  
  • Li, H.-O., Zhu, Y.-F., Asakawa, M., Kuma, H., Hirata, T., Ueda, Y., Lee, Y.-S., Fukumura, M., Iida, A., Kato, A., Nagai, Y., Hasegawa, M. (2000). A Cytoplasmic RNA Vector Derived from Nontransmissible Sendai Virus with Efficient Gene Transfer and Expression. J. Virol. 74: 6564-6569 [Abstract] [Full Text]  
  • Valmori, D., Levy, F., Miconnet, I., Zajac, P., Spagnoli, G. C., Rimoldi, D., Lienard, D., Cerundolo, V., Cerottini, J.-C., Romero, P. (2000). Induction of Potent Antitumor CTL Responses by Recombinant Vaccinia Encoding a Melan-A Peptide Analogue. J. Immunol. 164: 1125-1131 [Abstract] [Full Text]  
  • Subklewe, M., Chahroudi, A., Schmaljohn, A., Kurilla, M. G., Bhardwaj, N., Steinman, R. M. (1999). Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus. Blood 94: 1372-1381 [Abstract] [Full Text]  
  • Gnant, M. F. X., Puhlmann, M., Alexander, H. R. Jr., Bartlett, D. L. (1999). Systemic Administration of a Recombinant Vaccinia Virus Expressing the Cytosine Deaminase Gene and Subsequent Treatment with 5-Fluorocytosine Leads to Tumor-specific Gene Expression and Prolongation of Survival in Mice. Cancer Res. 59: 3396-3403 [Abstract] [Full Text]  
  • SCHULTZ, B. D., SINGH, A. K., DEVOR, D. C., BRIDGES, R. J. (1999). Pharmacology of CFTR Chloride Channel Activity. Physiol. Rev. 79: 109-144 [Abstract] [Full Text]  
  • Sanderson, C. M., Way, M., Smith, G. L. (1998). Virus-Induced Cell Motility. J. Virol. 72: 1235-1243 [Abstract] [Full Text]  
  • Alcami, A., Symons, J. A., Collins, P. D., Williams, T. J., Smith, G. L. (1998). Blockade of Chemokine Activity by a Soluble Chemokine Binding Protein from Vaccinia Virus. J. Immunol. 160: 624-633 [Abstract] [Full Text]  
  • Perera, L. P., Goldman, C. K., Waldmann, T. A. (2001). Comparative assessment of virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in immunodeficient mice. Proc. Natl. Acad. Sci. USA 98: 5146-5151 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»